Vaccine Weekly articles from October 2001

Vaccine Weekly archives from October 2001

Microparticle Adsorption Augments Efficacy.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - DNA-based HIV vaccines are more effective when delivered on the surface of charged particles, according to researchers in the United States. Derek...

Peptide Immunizations Lower Diabetic Incidence In Animal Model.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Stanford University researchers in California have developed a DNA vaccine that prevents animals from developing insulin-dependent diabetes mellitus (IDDM)....

Rhesus Monkeys Protected Against AIDS By Live Vaccine.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- More than 22 million people worldwide have died of AIDS. With millions of new infections each year, a safe and effective AIDS vaccine is imperative. In the past year or so, groups at Harvard...

Plant Virus-Based Vaccines Can Be Effective.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Plant viruses can be used as the basis for potent vaccines for HIV and possibly other infections, according to researchers in Italy. Eugenio Benvenuto...

High-Dose, Short-Interval Hep B Vaccine Works In Liver Disease Patients.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A higher dose, shorter interval hepatitis B vaccine regimen is effective for protecting patients with chronic liver disease who have yet to be affected by...

Some Vaccines May Boost Immune System.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Vaccines intended to protect people from getting AIDS may also work as a treatment for those already infected, boosting their immune system so they can temporarily stop taking AIDS drugs. ...

Cell Genesys Promotes Joseph Vallner To President.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Cell Genesys Inc. (CEGE) has promoted Joseph J. Vallner, PhD, to President from the position of Executive Vice President. Dr. Vallner will continue to serve as chief operating officer and work...

BTG Acquires Oral Vaccine Delivery Technology.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- BTG (BGC), a technology commercialization company, has acquired Bilosomes, a new oral vaccine delivery vesicle that protects antigens from the digestive process and can also act as an immunological...

Immunoconjugate Enhances Chemotherapy Effectiveness.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc. announced that its wholly owned subsidiary, AuraZyme Pharmaceuticals, Inc., presented results of animal studies on its A-Z-CINN Linker for targeted delivery of anticancer chemotherapy...

Second Quarter Losses Due To Stepped-up Spending on Ovarian Cancer Drug.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO), a developer of antigen-targeted antibody-based cancer therapeutics, reported a net loss of $7.5 million or $0.28 per share for the three months ended June 30, 2001 compared with...

Favorable Genetic Factors Same For Progression, Vaccine Efficacy.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Gene polymorphisms linked to favorable prognoses after HIV infection are also associated with positive responses to HIV vaccines, researchers say. ...

Pivotal Trial Completed, Primary Analysis Underway.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO.TO) announced that it has reached a major milestone in its OvaRex clinical development program - the completion for primary analysis of its designated pivotal 345-patient OvaRex...

Co-X-Gene Technology Will Target Advanced, Hormone-Refractory Disease.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Virax Holdings Ltd. (VHL) has entered into a collaborative agreement with Dr. Michael Brown of Royal Adelaide Hospital's Cancer Centre to develop leads for an immune-based therapy to treat prostate...

FDA Places Clinical Hold On Vaccine Trials.(Brief Article)
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- AVAX Technologies Inc. (AVXT), has submitted its response to the Food and Drug Administration's (FDA) clinical holds of the company's M-Vax and O-Vax autologous cancer vaccine clinical trials....

Modified Vaccinia Virus Ankara Repeat Dosing May Limit Effectiveness.(Brief Article)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Multiple administration of some HIV vaccines may reduce their efficacy, researchers in Europe and the United States warn. "A major aim in AIDS vaccine...

Bystander Effect Seen After Vector Administration.(Brief Article)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Gene therapies containing herpes simplex enzymes might be useful for immunizing patients against the formation of new tumors, according to scientists...

Vaccine Employing Novel Vector Protects Monkeys From Monkey-Human Hybrid Virus.(Brief Article)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Yale researchers have developed an AIDS vaccine that has proved effective in animal studies and holds promise for humans. "Based on our results, we think it is likely that this vaccine could...

Immunological Gene Therapy And Tumor Debulking Delays Mesothelioma Growth.(Brief Article)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Patients with malignant mesothelioma might benefit from augmentative therapies combining immunological gene therapy with tumor debulking. The process...

Shigella-Based Vector Causes Specific Immune Response.(Brief Article)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Genetic material from an E. coli-like bacteria and an HIV coat protein can be used to provoke HIV specific immune responses in mice, according to...

Recombinant Influenza Vectors Produce Antiviral Response.(Brief Article)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hyperattenuated flu viruses transfected with HIV genetic material may be able to help prevent HIV infection, researchers in Austria report. Boris...

Family Exposure To Hepatitis B Yields Faster Vaccine Immunity.(Brief Article)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Somehow, exposure to family members with chronic hepatitis B increases the rate at which other family members become immune to the virus after vaccination,...

Epimmune Provides HIV Vaccine Program Update.(Brief Article)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Epimmune Inc., presenting at the AIDS Vaccine 2001 Conference held in Philadelphia, Pennsylvania, September 7, 2001, provided additional information on its HIV vaccine program including its initial...

New Technology May Advance AIDS Vaccine Development.(Brief Article)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- ViroLogic, Inc. announced that an enhanced version of its PhenoSense HIV drug resistance assay can measure the potential effectiveness of AIDS vaccines in development faster, more efficiently and...

Promising Preclinical Results With Immunotherapeutic Agent.(HIV vaccine research)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- CEL-SCI Corporation presented a poster at the AIDS Vaccine 2001 Congress held in Philadelphia, Pennsylvania entitled "C Clade HGP-30 (p17 aa 86-115) Based Peptide Conjugates as Potential...

Novel Vaccine Has Potent Anticancer Activity.(Theratope from Biomira Inc.)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Biomira Inc. announced that its lead product candidate, Theratope vaccine, has been reviewed in the September 2001 issue of Ashley Publications' Expert Opinion on Biological Therapy, a United...

AlleCure Corp. Collaborates With BD Biosciences On Vaccine Evaluation.(Alle Vax allergy vaccine evaluation)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- AlleCure Corp. has agreed to collaborate with BD Biosciences (BDB), a division of Becton, Dickinson and Co., to develop novel assays in support of AlleCure's AlleVax treatments for allergies and...

No Solution In Sight For Shortage Of Vaccine For Military Personnel.(anthrax vaccine)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- The prospect of a major U.S. military campaign against terrorism comes as the Pentagon grows ever closer to running out of vaccine for the deadly anthrax virus. Pentagon officials declined to...

AIDS Vaccine Testing To Accelerate In Uganda.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- The International AIDS Vaccine Initiative (IAVI) and the government of the Republic of Uganda have signed a partnership agreement aimed at accelerating the development and testing of preventive...

Vaccinated Monkeys Pass 600-Day Mark With No Illness.(AIDS vaccine research results)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- For 600 days and counting, monkeys given an experimental new AIDS vaccine have survived with no signs of illness despite exposure to lethal doses of virus, raising hopes that scientists may be...

Trial Initiated Against Antibody-Mediated Stroke And Deep-Vein Thrombosis.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- La Jolla Pharmaceutical Company announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a Phase I/II clinical trial of...

Iguazu Biosciences To Develop HIV Vaccines Under License From UCSF.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Iguazu Biosciences Corp. announced during the AIDS Vaccine 2001 Conference that it was formed to pursue research, manufacturing and clinical development of a novel generation of HIV vaccines. ...

Elderly Black Patients Less Likely To Get Flu Vaccination.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- While the rate of influenza vaccination is higher for Medicare beneficiaries enrolled in managed care plans, racial disparity in vaccination is not reduced, according to an article in the September...

Sri Lankan Military, Tamil Rebels Call Truce For Vaccination Program.(for child polio prevention)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Sri Lanka security forces and Tamil rebels have agreed to cease hostilities for four days to facilitate the immunization of children against polio in areas characterized by heavy fighting in Sri...

Cholera, Diphtheria, Typhoid Protein Targets Discovered.(bacterial infection progression cause research)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Scientists from the University of Birmingham, England, have identified dozens of new target proteins thought to be involved in the disease processes of a range of bacterial infections. These...

Biomira Initiates Exploratory Phase Ib Trial With Patient-Specific Cancer Vaccines.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Biomira USA, a subsidiary of Biomira Inc., has initiated a Phase Ib clinical trial to test safety and immunogenicity of an autologous vaccine strategy for the treatment of B-cell lymphoma. This...

CEL-SCI Corporation Extends Agreement With U.S. Navy For Vaccine Collaboration.(malaria vaccine)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- CEL-SCI Corporation announced that its Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Center (NMRC) of the U.S. Navy to jointly develop a malaria vaccine...

Phase III Trials Of Natalizumab To Begin Soon.(Antegren monoclonal antibody)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Antegren (natalizumab), a humanized monoclonal antibody, demonstrated promising results on multiple endpoints in a Phase II study in multiple sclerosis (MS), according to data presented September...

Antinicotine Vaccine TA-NIC Enters Phase I Trials.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Xenova Group plc (XEN) has announced that its novel therapeutic vaccine, TA-NIC, which is being developed for the treatment of nicotine addiction, has entered Phase I clinical trials. The...

Cases Of Whooping Cough Increase In Texas' Rio Grande Valley.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- The number of cases of whooping cough in the Rio Grande Valley have nearly doubled since last year, according to Texas health officials. There were 24 cases of whooping cough, a highly...

Progenics, Cytogen Team To Develop Novel Vaccine.(for prostate cancer)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- PSMA Development Co. LLC has entered into an exclusive licensing agreement with AlphaVax Human Vaccines Inc. to use the AlphaVax Replicon Vector (ArV) system to create a therapeutic prostate cancer...

Vaccine Generates Powerful Immune Responses In Preclinical Studies.(prostate cancer vaccine)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- The PSMA Development Company LLC, a joint venture of Progenics Pharmaceuticals, Inc. and Cytogen Corporation, has entered into a worldwide exclusive licensing agreement with AlphaVax Human...

Large Phase II Study Of Monoclonal Antibody Initiated in U.S.(MedImmune Inc. starts psoriasis treatment research)
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc. announced September 17, 2001, that it has begun treating psoriasis patients with siplizumab (MEDI-507) in a large Phase II clinical trial. This trial, which is to enroll...

Navy Awards $3.5 Million To Develop 'Needleless' Vaccination.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- The University of Alabama at Birmingham has been awarded a $3.5 million contract from the Office of Naval Research to establish a vectored vaccine laboratory focusing on the development of...

Recombinant Bordetella Boosts Neisseria Vaccine Development.(meningitis vaccine)
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A better way of preparing vaccines against Neisseria meningitidis may soon be on the horizon if studies now being performed in France continue to show positive...

Plasmid DNA Delivery Of Attenuated Virus Inefficient.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Live-attenuated HIV vaccines based on plasmid DNA or proviral constructs are not yet a promising area of study, researchers in Australia argue. "Delivery...

Hepatitis Vaccination Programs Prevent Infant Deaths In Taiwan.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Officials in Taiwan say a massive hepatitis B vaccination program instituted 17 years ago has been responsible for declining infant mortality. Retrieving...

Routine Hepatitis A Vaccine Programs Needed For At-Risk Populations.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - An evaluation of several population groups in Vancouver, Canada shows some groups need to be targeted for routine hepatitis A virus (HAV) vaccine programs. ...

Interleukin-2 Fusion Protein Enhances DNA Vaccine Effectiveness.(DNA tumor vaccine)
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Researchers at Scripps Clinic and Research Institute in California have used a cytokine fusion protein to heighten the effectiveness of oral DNA vaccine...

Three New Patents Covering HIV Immunotherapeutic Agents Issued.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- CEL-SCI Corporation announced September 19, 2001, the issuance of three new U.S. patents, further expanding the patent protection related to its HIV-1 based therapeutic and preventive vaccines. ...

Dendreon Acquires Rights To Key Cancer Antigens From Bayer.(CEA and MN antigens)
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Dendreon Corp. (DNDN) today announced it has entered into agreements with Bayer, Tarrytown, New York, to license two prominent tumor antigens for use in Dendreon's therapeutic cancer vaccines. The...

AVANT Gets Patent Protection For Intellectual Property Of Anticholesterol Agent.(AVANT Immunotherapeutics Inc. has patent for CETi-1)
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- AVANT Immunotherapeutics Inc. (AVAN) has received a U.S. patent covering DNA immunogenic compositions for modulating endogenous cholesteryl ester transfer protein (CETP). The company also signed an...

AlleCure Establishes California Headquarters.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- AlleCure Corp., a biopharmaceutical company developing and discovering vaccines and therapies for allergies and autoimmune diseases, has established corporate headquarters in the Valencia Commerce Park...

Moving Gene In Plant Results In Increased Production Of Amino Acid.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- By placing a nuclear gene in another location - its original home in a plant - researchers have successfully enhanced the production of an essential amino acid. The work suggests that alterations...

Differences In Infection Routes May Complicate Development.(of AIDS vaccines)
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - HIV infection follows different patterns depending on the means of transmission, which need to be taken into account during vaccine studies, researchers in the...

Vaccine To Undergo Phase II Clinical Trial In Nepal.(hepatitis E vaccine)
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Genelabs Technologies, Inc. announced September 25, 2001, the initiation of a Phase II clinical trial of an investigational new vaccine for prevention of disease caused by hepatitis E virus (HEV). ...

Plexus Vaccine Licenses Molsoft To Develop Proprietary Virtual Epitope Databases.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Plexus Vaccine Inc. and Molsoft LLC have entered into a key licensing agreement to discover and commercialize new interventional strategies for global infectious diseases, for drug-resistant microbes,...

Aventis Pasteur To Complete Flu Vaccine Shipments By November.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur, the nation's leading supplier of influenza vaccine, says it anticipates shipping all influenza vaccine orders to customers by the end of November (2001). Smaller customers were...

Liposomal Vaccine Shows Specific Immunotherapy In Stage III Disease.(non-small cell lung cancer)
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Biomira, Inc. reports that its liposomal candidate vaccine has shown specific immunotherapy in a Phase I study of non-small cell lung cancer. The trial involved 16 evaluable patients with non-small...

LigoCyte Pharmaceuticals Collaborates With NIH To Develop Mucosal Vaccine.(National Institute of Allergy and Infectious Diseases)
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- LigoCyte Pharmaceuticals Inc. has entered into a Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) for the development and...

Viral Control After Early Antiretroviral Treatment May Guide Vaccine Research.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Antiretroviral treatment given during acute simian immunodeficiency virus (SIV) infection enables natural viral control after therapy cessation, researchers in...

New Vaccine Strategy Targets Tumor Growth Factors With Gene Therapy.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Using gene therapy, researchers have immunized mice against a major growth factor responsible for tumor growth. Researchers in China at Sichuan University...

Vesicular Stomatitis Virus Vector Effective.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A potential HIV vaccine using a modified vesicular stomatitis virus (VSV)-based vector has shown promise in animal studies, according to researchers in the...

Rare Blowel Blockage Linked To Vaccine Has Lower Incidence Than Thought.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- A study in The Lancet concludes that the risk of intussusception, a bowel obstruction, in infants vaccinated against severe rotavirus diarrhea was substantially lower than previous reports estimated....

Coimmunization Leads To Immune Response In Woodchuck Hepatitis Model.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- by Sonia Bell-Nichols, senior medical writer - Coimmunization with plasmids encoded for interleukin (IL)-12 appears to boost Th1 cytokine response and protective immunity in animals vaccinated with the...

Researchers Say There Will Be An AIDS Vaccine Within 10 Years.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- Researchers are optimistic an AIDS vaccine will be available within 10 years, but it's unlikely to be fully effective against all strains of the virus, a U.S. health expert said. Margaret...

Barr Awarded $35 Million Department Of Defense Contract.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc. announced September 28, 2001, that it has been awarded a $35.4 million, six-year contract from the United States Department of Defense for development of adenovirus vaccines...

AlleCure Announces Alliance With BD Biosciences.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- AlleCure Corp. will collaborate with BD Biosciences (BDB), a division of BD (Becton, Dickinson and Co.), to develop novel assays in support of AlleCure's AlleVax treatments for allergies and various...

Engineered Antibodies Accelerating Drug Discovery And Development Conference Rescheduled.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- The world antibodies research community will be convening in Philadelphia, Pennsylvania, on October 22-23, 2001, to attend, speak, and exhibit at "Engineered Antibodies Accelerating Drug Discovery and...

Canarypox-Based Vaccines Trigger (gamma) (delta) T-Cell Activity.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - HIV and other vaccines using canarypox vectors provoke enhanced (gamma) (delta) T-cell responses compared with other vaccines, researchers in Missouri report....

University Team Visits Honduras During Vaccine Work.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- Hookworm infection is a major public health problem in many developing countries. A team from George Washington Medical Center traveled to one such country, Honduras, for a four-day fact-finding site...

Sperm Antigen Might Be Good Contraception, Solve Reproductive Problems.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The new discovery of a cDNA fragment that encodes for sperm antigen could some day be used for developing methods that enhance human reproductive medicine....

Edible Hepatitis B Vaccine May Be On The Horizon, Could Eradicate Virus.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - In the not so distant future, hepatitis B vaccinations could be dispensed at the farmer's market instead of the doctor's office. Researchers used uncooked...

Epimmune Grants License For Ex Vivo Applications Of Cancer Epitopes.
October 24, 2001... 2001 OCT 24 - (NewsRx.com & NewsRx.net) -- Epimmune Inc. has granted Anosys Inc., formerly AP Cells, a nonexclusive license to certain cancer antigens for use in Anosys' cancer therapy program. The license covers certain patented and...